UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 135

Sortiert nach

Lower Circulating B12 Is Associated with Higher Obesity and Insulin Resistance during Pregnancy in a Non-Diabetic White British Population

PloS one, 2015-08, Vol.10 (8), p.e0135268-e0135268

2015

Link zum Volltext

Verfügbarkeit prüfen

Dirichlet process mixture models to impute missing predictor data in counterfactual prediction models: an application to predict optimal type 2 diabetes therapy

BMC medical informatics and decision making, 2024-01, Vol.24 (1), p.12-12, Article 12

2024

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia

JAMA : the journal of the American Medical Association, 2014-01, Vol.311 (3), p.279

2014

Link zum Volltext

Verfügbarkeit prüfen

Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies

PloS one, 2013-06, Vol.8 (6), p.e65326

2013

Link zum Volltext

Verfügbarkeit prüfen

Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study

Nature medicine, 2023-02, Vol.29 (2), p.376-383

2023

Link zum Volltext

Verfügbarkeit prüfen

Glycated haemoglobin measurements from UK Biobank are different to those in linked primary care records: implications for combining biochemistry data from research studies and routine clinical care

International journal of epidemiology, 2022-06, Vol.51 (3), p.1022-1024

2022

Link zum Volltext

Verfügbarkeit prüfen

Should Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c?

PloS one, 2016-04, Vol.11 (4), p.e0152428-e0152428

2016

Link zum Volltext

Verfügbarkeit prüfen

Development of a clinical calculator to aid the identification of MODY in pediatric patients at the time of diabetes diagnosis

Scientific reports, 2024-05, Vol.14 (1), p.10589-10589

2024

Link zum Volltext

Verfügbarkeit prüfen

Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database

Diabetes care, 2016-02, Vol.39 (2), p.258-263

2016

Link zum Volltext

Verfügbarkeit prüfen

Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy

Cardiovascular diabetology, 2023-11, Vol.22 (1), p.302-302, Article 302

2023

Link zum Volltext

Verfügbarkeit prüfen

Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study

Nature medicine, 2023-02, Vol.29 (2), p.384-391

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparison of causal forest and regression-based approaches to evaluate treatment effect heterogeneity: an application for type 2 diabetes precision medicine

BMC medical informatics and decision making, 2023-06, Vol.23 (1), p.110-110, Article 110

2023

Link zum Volltext

Verfügbarkeit prüfen

Genetic effects on the timing of parturition and links to fetal birth weight

Nature genetics, 2023-04, Vol.55 (4), p.559-567

2023

Link zum Volltext

Verfügbarkeit prüfen

Correction to: The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis

Diabetologia, 2023-08, Vol.66 (8), p.1585-1585

2023

Link zum Volltext

Verfügbarkeit prüfen

Choice of HbA1c threshold for identifying individuals at high risk of type 2 diabetes and implications for diabetes prevention programmes: a cohort study

BMC medicine, 2021-08, Vol.19 (1), p.184-11, Article 184

2021

Link zum Volltext

Verfügbarkeit prüfen

Prior event rate ratio adjustment produced estimates consistent with randomized trial: a diabetes case study

Journal of clinical epidemiology, 2020-06, Vol.122, p.78-86

2020

Link zum Volltext

Verfügbarkeit prüfen

Assessing whether genetic scores explain extra variation in birthweight, when added to clinical and anthropometric measures

BMC pediatrics, 2022-08, Vol.22 (1), p.1-504, Article 504

2022

Link zum Volltext

Verfügbarkeit prüfen

Identifying good responders to glucose lowering therapy in type 2 diabetes: implications for stratified medicine

PloS one, 2014-10, Vol.9 (10), p.e111235-e111235

2014

Link zum Volltext

Verfügbarkeit prüfen

Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study

BMJ open, 2024-01, Vol.14 (1), p.e078135-e078135

2024

Link zum Volltext

Verfügbarkeit prüfen

EDTA improves stability of whole blood C-peptide and insulin to over 24 hours at room temperature

PloS one, 2012-07, Vol.7 (7), p.e42084-e42084

2012

Link zum Volltext

Verfügbarkeit prüfen

Performance of European prediction models for classification of type 1 and type 2 diabetes in Indians

Diabetes & metabolic syndrome clinical research & reviews, 2024-04, Vol.18 (4), p.103007-103007, Article 103007

2024

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide association study of placental weight identifies distinct and shared genetic influences between placental and fetal growth

Nature genetics, 2023-11, Vol.55 (11), p.1807-1819

2023

Link zum Volltext

Verfügbarkeit prüfen

Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes

Diabetologia, 2019-07, Vol.62 (7), p.1167-1172

2019

Link zum Volltext

Verfügbarkeit prüfen

Investigating the causal effect of maternal vitamin B12 and folate levels on offspring birthweight

International journal of epidemiology, 2021-03, Vol.50 (1), p.179-189

2021

Link zum Volltext

Verfügbarkeit prüfen

Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis

British journal of general practice, 2016-05, Vol.66 (646), p.e315-e322

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 135

Suche als RSS-Feed

Aktive Filter

ThemaEndocrinology & Metabolism

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(116)

Publikationsform

Artikel
(135)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(83)
Science & Technology
(76)
Life Sciences & Biomedicine
(63)
Diabetes
(50)
Female
(50)
Male
(44)
Adult
(34)
Biological And Medical Sciences
(29)
Risk Factors
(29)
Middle Aged
(26)
Genetic Aspects
(23)
Genetics & Heredity
(21)
Insulin
(20)
Medical Sciences
(20)
Diabetes Mellitus
(19)
Diabetes Mellitus, Type 2 - Genetics
(19)
Polymorphism, Single Nucleotide
(19)
Type 2 Diabetes
(19)
Case-Control Studies
(18)
Medicine
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Lower Circulating B12 Is Associated with Higher Obesity and Insulin Resistance during Pregnancy in a Non-Diabetic White British Population

Dirichlet process mixture models to impute missing predictor data in counterfactual prediction models: an application to predict optimal type 2 diabetes therapy

Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia

Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies

Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study

Glycated haemoglobin measurements from UK Biobank are different to those in linked primary care records: implications for combining biochemistry data from research studies and routine clinical care

Should Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c?

Development of a clinical calculator to aid the identification of MODY in pediatric patients at the time of diabetes diagnosis

Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database

Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy

Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study

Comparison of causal forest and regression-based approaches to evaluate treatment effect heterogeneity: an application for type 2 diabetes precision medicine

Genetic effects on the timing of parturition and links to fetal birth weight

Correction to: The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis

Choice of HbA1c threshold for identifying individuals at high risk of type 2 diabetes and implications for diabetes prevention programmes: a cohort study

Prior event rate ratio adjustment produced estimates consistent with randomized trial: a diabetes case study

Assessing whether genetic scores explain extra variation in birthweight, when added to clinical and anthropometric measures

Identifying good responders to glucose lowering therapy in type 2 diabetes: implications for stratified medicine

Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study

EDTA improves stability of whole blood C-peptide and insulin to over 24 hours at room temperature

Performance of European prediction models for classification of type 1 and type 2 diabetes in Indians

Genome-wide association study of placental weight identifies distinct and shared genetic influences between placental and fetal growth

Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes

Investigating the causal effect of maternal vitamin B12 and folate levels on offspring birthweight

Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis

Aktive Filter

Suchergebnisse filtern